53.600
53.60 (0%)
As of Dec 20, 2024
Crinetics Pharmaceuticals, Inc. [CRNX]
Source:
Company Overview
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors. Endocrine pathways function to maintain homeostasis and commonly use peptide hormones acting through GPCRs to regulate many aspects of physiology, including growth, energy, metabolism, gastrointestinal function and stress responses.
Country | United States |
Headquarters | san diego, california |
Phone Number | (858) 450-6464 |
Industry | manufacturing |
CEO | R. Scott Struthers, Ph.D. |
Website | www.crinetics.com |